Abbott Laboratories (ABT) stock
ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3049% above fair value
$108.52+1.27 (+1.18%)
Close on Nov 13, 2026Market cap $187.78BP/E 40.2Yield 2.21%
Abbott Laboratories operating margin
Operating margin is operating income as a percentage of revenue.
Abbott Laboratories's operating margin for the twelve months ending Sep 30, 2026 was 13.8%. For fiscal 2025 it was 18.2%, against 16.3% the year before. The highest annual figure on record is 20.3% in fiscal 2009.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 18.2% | +1.9 |
| FY2024 | Dec 31, 2024 | 16.3% | +0.1 |
| FY2023 | Dec 31, 2023 | 16.2% | −3.0 |
| FY2022 | Dec 31, 2022 | 19.2% | −0.4 |
| FY2021 | Dec 31, 2021 | 19.6% | +4.1 |
| FY2020 | Dec 31, 2020 | 15.5% | +1.3 |
| FY2019 | Dec 31, 2019 | 14.2% | +2.3 |
| FY2018 | Dec 31, 2018 | 11.9% | +6.2 |
| FY2017 | Dec 31, 2017 | 5.7% | −8.8 |
| FY2016 | Dec 31, 2016 | 14.5% | +0.5 |
| FY2015 | Dec 31, 2015 | 14.1% | +1.2 |
| FY2014 | Dec 31, 2014 | 12.8% | +2.0 |
| FY2013 | Dec 31, 2013 | 10.9% | +3.7 |
| FY2012 | Dec 31, 2012 | 7.1% | −0.5 |
| FY2011 | Dec 31, 2011 | 7.6% | −9.7 |
| FY2010 | Dec 31, 2010 | 17.3% | −3.0 |
| FY2009 | Dec 31, 2009 | 20.3% | +1.0 |
| FY2008 | Dec 31, 2008 | 19.3% | +1.6 |
| FY2007 | Dec 31, 2007 | 17.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 10.4% | −7.7 |
| Q2 FY2026 | Jun 30, 2026 | 13.4% | −5.0 |
| Q1 FY2026 | Mar 31, 2026 | 12.0% | −4.3 |
| Q4 FY2025 | Dec 31, 2025 | 19.6% | +2.2 |
| Q3 FY2025 | Sep 30, 2025 | 18.1% | +0.6 |
| Q2 FY2025 | Jun 30, 2025 | 18.4% | +2.3 |
| Q1 FY2025 | Mar 31, 2025 | 16.3% | +2.4 |
| Q4 FY2024 | Dec 31, 2024 | 17.4% | +0.0 |
| Q3 FY2024 | Sep 30, 2024 | 17.5% | +1.2 |
| Q2 FY2024 | Jun 30, 2024 | 16.1% | +0.6 |
| Q1 FY2024 | Mar 31, 2024 | 13.9% | −1.6 |
| Q4 FY2023 | Dec 31, 2023 | 17.4% | +4.5 |
| Q3 FY2023 | Sep 30, 2023 | 16.2% | −0.8 |
| Q2 FY2023 | Jun 30, 2023 | 15.5% | −5.7 |
| Q1 FY2023 | Mar 31, 2023 | 15.5% | −9.0 |
| Q4 FY2022 | Dec 31, 2022 | 12.9% | −7.8 |
| Q3 FY2022 | Sep 30, 2022 | 17.0% | −6.3 |
| Q2 FY2022 | Jun 30, 2022 | 21.1% | +7.5 |
| Q1 FY2022 | Mar 31, 2022 | 24.5% | +4.3 |
| Q4 FY2021 | Dec 31, 2021 | 20.7% | −2.0 |
| Q3 FY2021 | Sep 30, 2021 | 23.3% | +6.4 |
| Q2 FY2021 | Jun 30, 2021 | 13.6% | +4.4 |
| Q1 FY2021 | Mar 31, 2021 | 20.2% | +10.4 |
| Q4 FY2020 | Dec 31, 2020 | 22.7% | +6.0 |
| Q3 FY2020 | Sep 30, 2020 | 16.9% | +2.1 |
| Q2 FY2020 | Jun 30, 2020 | 9.2% | −5.9 |
| Q1 FY2020 | Mar 31, 2020 | 9.8% | +0.0 |
| Q4 FY2019 | Dec 31, 2019 | 16.7% | +1.7 |
| Q3 FY2019 | Sep 30, 2019 | 14.8% | +1.8 |
| Q2 FY2019 | Jun 30, 2019 | 15.1% | +3.8 |
| Q1 FY2019 | Mar 31, 2019 | 9.8% | +1.6 |
| Q4 FY2018 | Dec 31, 2018 | 15.0% | +6.4 |
| Q3 FY2018 | Sep 30, 2018 | 13.0% | +1.7 |
| Q2 FY2018 | Jun 30, 2018 | 11.4% | +5.5 |
| Q1 FY2018 | Mar 31, 2018 | 8.2% | +12.0 |
| Q4 FY2017 | Dec 31, 2017 | 8.6% | −6.2 |
| Q3 FY2017 | Sep 30, 2017 | 11.3% | – |
| Q2 FY2017 | Jun 30, 2017 | 5.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -3.8% | – |
| Q4 FY2016 | Dec 31, 2016 | 14.8% | – |
See a number that looks wrong?